Home›People›Alexander Nolte
AN

Alexander Nolte

Executive officer at Crossbow Therapeutics.

ExecutivePublic company
Updated Oct 27, 2026·Latest SEC filing Sep 30, 2025·Suggest an edit

About Alexander Nolte

Alexander Nolte is an executive officer at Crossbow Therapeutics.

Alexander Nolte reports to the SEC as an officer of 2 public companies: Oncorus (ONCR) and Syndax Pharmaceuticals (SNDX).

Alexander Nolte first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Alexander Nolte in the role, so the role may have started earlier or lasted longer.

Crossbow Therapeutics, Inc.
Executive officer
2025 · Cambridge, MA
Oncorus, Inc.
Interim CFO
2023 · Public company (ONCR)
Syndax Pharmaceuticals Inc
Chief Accounting Officer
2021 – 2023 · Public company (SNDX)

Key Colleagues at Startups

The people Alexander Nolte works with at each company, as listed on that company's latest Form D.

Crossbow Therapeutics, Inc. · Form D, Sep 30, 2025
DW
Dmitri Wiederschain
Executive officer
SA
CB
Charles Baum
Director
Briggs Morrison
Briggs Morrison
Chief Executive Officer and director
IM
AL
Alon Lazarus
Director
TF
Todd Foley
Director

Sources

  1. SECCrossbow Therapeutics, Inc. Form D, filed Sep 30, 2025
  2. SECForms 3, 4 and 5 filed by Alexander Nolte (SEC filer 1891979)